{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:54:28Z","timestamp":1791226468917,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:00:00Z","timestamp":1710460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ejps.2024.106751","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T16:40:21Z","timestamp":1710780021000},"page":"106751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Enabling a novel solvent method on Albendazole solid dispersion to improve the in vivo bioavailability"],"prefix":"10.1016","volume":"196","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7062-0681","authenticated-orcid":false,"given":"Ming-Jie","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyang Zack","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2024.106751_bib0001","article-title":"Effect of pH modifiers on the solubility, dissolution rate, and stability of telmisartan solid dispersions produced by hot-melt extrusion technology","volume":"65","author":"Almotairy","year":"2021","journal-title":"J. Drug. Deliv. Sci. Technol."},{"key":"10.1016\/j.ejps.2024.106751_bib0002","article-title":"Application of microenvironmental pH modified technology in solid dispersions","volume":"20","author":"Bai","year":"2011","journal-title":"Chin. J. New Drug."},{"key":"10.1016\/j.ejps.2024.106751_bib0003","doi-asserted-by":"crossref","first-page":"6394","DOI":"10.1039\/C8CE01311J","article-title":"Novel pharmaceutical salts of albendazole","volume":"20","author":"Bolla","year":"2018","journal-title":"CrystEngComm"},{"key":"10.1016\/j.ejps.2024.106751_bib0004","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1080\/10837450.2020.1783553","article-title":"Albendazole solid dispersions prepared using PEG6000 and Poloxamer188: formulation, characterization and in vivo evaluation","volume":"25","author":"Dong","year":"2020","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejps.2024.106751_bib0005","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.xphs.2021.11.010","article-title":"Dissolution\/permeation of Albendazole in the presence of cyclodextrin and bile salts: a mechanistic in vitro study into factors governing oral bioavailability","volume":"111","author":"Eriksen","year":"2022","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2024.106751_bib0006","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.1021\/acs.chemrev.0c00812","article-title":"Using microemulsions: formulation based on knowledge of their mesostructure","volume":"121","author":"Gradzielski","year":"2021","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejps.2024.106751_bib0007","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S1473-3099(17)30484-X","article-title":"Global deworming: moving past albendazole and mebendazole","volume":"17","author":"Hotez","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejps.2024.106751_bib0008","first-page":"618","article-title":"Inhibition of albendazole crystallization in poly(vinylpyrrolidone) solid molecular dispersions","volume":"61","author":"Kalaiselvan","year":"2006","journal-title":"Pharmazie"},{"key":"10.1016\/j.ejps.2024.106751_bib0009","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1021\/acsanm.0c00606","article-title":"Nanoparticle-based drugs and formulations: current status and emerging applications","volume":"3","author":"Kumar","year":"2020","journal-title":"ACS Appl. Nano Mater."},{"key":"10.1016\/j.ejps.2024.106751_bib0010","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0939-6411(00)00076-X","article-title":"Improving drug solubility for oral delivery using solid dispersions","volume":"50","author":"Leuner","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2024.106751_bib0011","doi-asserted-by":"crossref","DOI":"10.3390\/ph13110383","article-title":"Preparation and characterization of solid dispersions composed of curcumin, hydroxypropyl cellulose and\/or sodium dodecyl sulfate by grinding with vibrational ball milling","volume":"13","author":"Mai","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.ejps.2024.106751_bib0012","unstructured":"Malik K., Dua A. Albendazole. StatPearls. Treasure Island (FL) ineligible companies. Disclosure: anterpreet Dua declares no relevant financial relationships with ineligible companies. 2023."},{"key":"10.1016\/j.ejps.2024.106751_bib0013","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5916013","article-title":"Current Trends on Solid Dispersions: past, Present, and Future","author":"Malkawi","year":"2022","journal-title":"Adv. Pharmacol. Pharm. Sci."},{"key":"10.1016\/j.ejps.2024.106751_bib0014","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijpharm.2016.01.006","article-title":"A novel hot-melt extrusion formulation of albendazole for increasing dissolution properties","volume":"499","author":"Martinez-Marcos","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2024.106751_bib0015","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2478\/v10007-012-0031-0","article-title":"Formulation development of an albendazole self-emulsifying drug delivery system (SEDDS) with enhanced systemic exposure","volume":"62","author":"Meena","year":"2012","journal-title":"Acta Pharm."},{"key":"10.1016\/j.ejps.2024.106751_bib0016","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11020375","article-title":"Effect of pH, ionic strength and agitation rate on dissolution behaviour of 3D-printed tablets, tablets prepared from ground hot-melt extruded filaments and physical mixtures","volume":"11","author":"Nashed","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejps.2024.106751_bib0017","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.5005\/jp-journals-10005-2577","article-title":"A comparative evaluation of dissolution rate of three different posterior restorative materials used in pediatric dentistry: an in vitro study","volume":"16","author":"Raman","year":"2023","journal-title":"Int. J. Clin. Pediatr. Dent."},{"key":"10.1016\/j.ejps.2024.106751_bib0018","doi-asserted-by":"crossref","first-page":"13330","DOI":"10.1021\/acs.jmedchem.0c00910","article-title":"Anti-giardia drug discovery: current status and gut feelings","volume":"63","author":"Riches","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2024.106751_bib0019","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.4155\/fmc-2022-0225","article-title":"The key new techniques in the medicinal chemist's toolkit to prioritize solubility during drug design","volume":"14","author":"Sahu","year":"2022","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejps.2024.106751_bib0020","doi-asserted-by":"crossref","first-page":"15449","DOI":"10.1021\/acs.jmedchem.0c01502","article-title":"A structural analysis of the FDA green book-approved veterinary drugs and roles in human medicine","volume":"63","author":"Scott","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2024.106751_bib0021","article-title":"Antiparasitic drugs in the United States-two roads to high prices","volume":"5","author":"Shahriar","year":"2020"},{"key":"10.1016\/j.ejps.2024.106751_bib0022","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13020220","article-title":"Relevance of liquid-liquid phase separation of supersaturated solution in oral absorption of Albendazole from amorphous solid dispersions","volume":"13","author":"Suzuki","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2024.106751_bib0023","first-page":"50","article-title":"Simple and rapid spectrophotometric assay of Albendazole in pharmaceuticals using iodine and picric acid as CT complexing agents","author":"Swamy","year":"2014","journal-title":"Brazil. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejps.2024.106751_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2017.07.008","article-title":"Review - An update on the use of oral phospholipid excipients","volume":"108","author":"van Hoogevest","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2024.106751_bib0025","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1124\/pr.112.005660","article-title":"Strategies to address low drug solubility in discovery and development","volume":"65","author":"Williams","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejps.2024.106751_bib0026","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijpharm.2014.08.047","article-title":"Microenvironmental pH-modified solid dispersions to enhance the dissolution and bioavailability of poorly water-soluble weakly basic GT0918, a developing anti-prostate cancer drug: preparation, characterization and evaluation in vivo","volume":"475","author":"Yang","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2024.106751_bib0027","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1208\/s12249-018-1222-x","article-title":"Formulation and evaluation of a novel oral oil-based suspension using micro-environmental pH-modifying solid dispersion","author":"Zhang","year":"2019","journal-title":"AAPS PharmSciTech"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724000629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724000629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T11:03:04Z","timestamp":1715338984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098724000629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":27,"alternative-id":["S0928098724000629"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106751","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enabling a novel solvent method on Albendazole solid dispersion to improve the in vivo bioavailability","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106751","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106751"}}